ClinicalTrials.Veeva

Menu

Systems Biology of Amyotrophic Lateral Sclerosis (ALS)

Viome logo

Viome

Status

Not yet enrolling

Conditions

ALS
ALS (Amyotrophic Lateral Sclerosis)

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patient of Dr. Espíndola at UFSC

Exclusion criteria

Trial design

20 participants in 2 patient groups

ALS Cohort
Description:
Patients of Dr. Espíndola at UFSC that are diagnosed with ALS and meet the inclusion/exclusion criteria.
Control Cohort
Description:
Those that meet the inclusion/exclusion criteria, do not have ALS, and generally are healthy.

Trial contacts and locations

0

Loading...

Central trial contact

Momo Chief Science Officer, Head of Clinical Research, PhD; Raquel Clinical Research Coordinator, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems